BioXell
BioXell is a biomedical research institute focusing on chronic inflammatory disease and autoimmunity.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
$41.0m Valuation: $41.0m | Acquisition | ||
| Total Funding | 000k | ||
Thuja Capital(exited)
MPM BioImpact(exited)
Medicxi(exited)
EQT Life Sciences(exited)
BB Biotech Ventures(exited)
Finlombarda Gestioni SGR(exited)
TVM Capital Life Science(exited)
| EUR | 2015 | 2016 |
|---|---|---|
| Revenues | 0000 | 0000 |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Company filings or news article
Related Content
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads